Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational trophoblastic disease.

J O Schorge1, D P Goldstein, M R Bernstein

  • 1Division of Gynecologic Oncology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of minimally invasive versus open abdominal hysterectomy in patients with gestational trophoblastic disease.

Gynecologic oncology·2020
Same author

Important insights for non-molar choriocarcinoma.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer.

Gynecologic oncology·2020
Same author

Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.

Current oncology (Toronto, Ont.)·2019
Same author

HPV Status Improves Classification of Head and Neck Gray Zone Cancers.

Journal of dental research·2019
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Molar pregnancy is managed with surgery or chemotherapy based on risk and metastasis. Treatment for persistent trophoblastic tumors and placental-site tumors involves chemotherapy, surgery, or radiotherapy.

Area of Science:

  • Gynecology
  • Oncology
  • Reproductive Medicine

Background:

  • Molar pregnancy requires timely and risk-stratified management.
  • Persistent or metastatic trophoblastic tumors necessitate specific therapeutic approaches.

Purpose of the Study:

  • To outline current treatment strategies for molar pregnancy and related trophoblastic tumors.
  • To differentiate management based on risk, metastasis, and tumor type.

Main Methods:

  • Surgical interventions like suction curettage and hysterectomy are employed.
  • Single-agent chemotherapy (methotrexate) is used for low- to moderate-risk tumors.
  • Combination chemotherapy, radiotherapy, and surgery are utilized for high-risk and metastatic disease.

Main Results:

Related Experiment Videos

  • Treatment choice depends on fertility preservation needs and disease risk.
  • Hysterectomy is standard for placental-site trophoblastic tumors.
  • Metastatic disease often requires multimodal treatment including chemotherapy.

Conclusions:

  • A tailored approach is crucial for managing molar pregnancy and trophoblastic tumors.
  • Risk stratification guides the selection of chemotherapy, surgery, or radiotherapy.
  • Effective management strategies improve outcomes for patients with gestational trophoblastic disease.